Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals graded type 2 diabetes risk from normal pregnancy glucose levels across BMI groups, highlighting opportunities for earlier risk stratification.
AIMS: Gestational diabetes (GDM) is the strongest known risk factor for maternal type 2 diabetes. However, little is known about type 2 diabetes risk in women with normal glucose challenge test (GCT) results during pregnancy. We investigated the association between GCT results in the normal range and type 2 diabetes risk, both overall and across pre-pregnancy BMI categories. MATERIALS AND METHODS: This retrospective cohort study identified pregnant women aged 20-50 who had normal (< 140 mg/dL) GCT results between 2004 and 2022. Follow-up for type 2 diabetes extended from the date of the last documented GCT until 31 September 2024. Survival analyses examine GCT and combine BMI-GCT exposures. RESULTS: Among 249 190 eligible women (mean age 32.7 years), 1354 developed type 2 diabetes during a median follow-up of 7 years. GCT results within the normal range were associated with the risk of type 2 diabetes, in a graded manner, without a clear threshold. Compared to women with normal pre-pregnancy BMI and GCT of 70-89 mg/dL, women with a GCT of 130-140 mg/dL had adjusted hazard ratios for type 2 diabetes ranging from 14.7 (95% CI: 6.2-33.3) among women with normal BMI to 145 (95% CI: 67.7-309) among women with obesity. CONCLUSIONS: Pre-pregnancy BMI and GCT values within the normal range can be used for further type 2 diabetes risk stratification, ranging from minimal risk among women with a GCT < 90 mg/dL and normal weight to substantially increased risk among women with pre-pregnancy overweight or obesity.
No takes yet. Share an insight, caveat, or question.
Barer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: